- Home
- MESO vs HE Comparison
MESO vs HE Comparison
Compare MESO & HE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MESO | HE |
|---|---|---|
| Founded | 2004 | 1891 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2005 | 1994 |
Fundamental Metrics
Financial Performance| Metric | MESO | HE |
|---|---|---|
| Price | $11.96 | $8.44 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 3 | 4 |
| Target Price | ★ $37.00 | $8.63 |
| AVG Volume (30 Days) | 216.6K | ★ 2.7M |
| Earning Date | 08-26-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 106.32 |
| EPS | N/A | ★ 0.89 |
| Revenue | N/A | ★ $3,086,896,000.00 |
| Revenue This Year | $59.17 | $1.87 |
| Revenue Next Year | $59.00 | $4.21 |
| P/E Ratio | ★ N/A | $9.63 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.94 | $8.20 |
| 52 Week High | $21.50 | $17.33 |
Technical Indicators
Market Signals| Indicator | MESO | HE |
|---|---|---|
| Relative Strength Index (RSI) | 28.02 | 20.92 |
| Support Level | N/A | N/A |
| Resistance Level | $15.97 | $13.82 |
| Average True Range (ATR) | 0.40 | 0.21 |
| MACD | -0.12 | 0.05 |
| Stochastic Oscillator | 2.03 | 20.11 |
Price Performance
Historical ComparisonAbout MESO Mesoblast Limited
Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low back pain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform.
About HE Hawaiian Electric Industries Inc.
Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and owns a 10% minority interest in Hawaii's American Savings Bank. The utilities provide electricity on the islands of Oahu, Hawaii, Maui, Molokai, and Lanai.